Preventing pregnancy is largely viewed as the responsibility of anyone who can become pregnant. It’s a burden that can hold significant emotional, financial and physical weight (not just the bathroom scale kind).This article was originally […]
Endometriosis is a chronic inflammatory condition in which tissue similar to the lining of the uterus is also found outside the uterus. Symptoms include menstrual pain, chronic pelvic pain, pain during intercourse, and in some […]
During pregnancy, a mother’s body undergoes vast structural and functional changes. But what many might not know is that the after-effects of these changes can last long after giving birth—and can even result in the […]
A new Yale study published in JAMA Network Open finds that the virus that causes COVID-19 does not linger in placental tissue weeks to months after a pregnant woman recovers from infection—offering important reassurance for […]
Opioid use disorder during pregnancy remains a critical yet under-addressed public health issue in the U.S., according to a new study at Columbia University Mailman School of Public Health. Although effective, evidence-based treatments exist, many […]
Some of the earliest warning signs of breast cancer risk may be hidden deep within the molecular makeup of breast tissue—long before anything appears on a scan. To uncover those signals, researchers at MUSC Hollings […]
Physical activity during pregnancy enhances the metabolic health of offspring, but new research in mice indicates that prenatal stress blunts these benefits, at least in male offspring. The findings are published in The FASEB Journal.This […]
Hospitals that score poorly on feedback from female patients could soon see their budget cut under a plan unveiled in April by Wes Streeting, the UK’s health secretary. Branded “patient power payments,” the scheme would […]
A hormone procedure commonly offered to IVF patients globally as an “add-on” does not improve chances of falling pregnant, according to an international analysis led by the University of Sydney.This article was originally published on […]
A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and olaparib in Human Epidermal Growth Factor Receptor 2 (HER2)-expressing malignancies—including ovarian and uterine cancers—found a tolerable dosing schedule with promising […]
© 2025 SimplyWell.ca